The billionaire Poonawalla family have bought a £42mn building in London’s upmarket Grosvenor Square, around the corner from their Mayfair home, despite concerns that changes to the UK’s non-dom tax ...

While there is more uncertainty for markets ahead, Barclays' analysts still highlight a number of stocks in which they see ...

Treatment with metformin was associated with a reduction in asthma attacks among patients with asthma and type 2 diabetes, with additional reductions observed with the use of GLP-1 receptor agonists, ...

The Police arrested 59-year-old Deanna Chambers of Georgetown, Delaware, for theft of a controlled substance that occurred ...

Nice said it was ‘extremely disappointed’ it will be unable to recommend trastuzumab deruxtecan, sold under the brand name ...

Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...

A little more than a month after AstraZeneca jumped into the fray with the purchase of a rival heart drug candidate, Eli ...

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

AstraZeneca AZN announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended approving its ...

Lilly’s muvalaplin is the first oral drug to show positive Phase II findings for Lp(a) reduction, eliciting up to an 86% drop ...

Tagrisso has been recommended for approval in the European Union for the treatment of adult patients with locally advanced, ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended AstraZeneca's Tagrisso ...